Medicare Enrolled

Dr. Nilanjan Gajare, M.D.

Psychiatry · Kalamazoo, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1312 OAKLAND DR, Kalamazoo, MI 49008
2693373199
In practice since 2006 (19 years)
NPI: 1972616191 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gajare from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gajare? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gajare

Dr. Nilanjan Gajare is a psychiatry specialist in Kalamazoo, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gajare performed 830 Medicare services across 277 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gajare received a total of $19,878 from 27 pharmaceutical and/or device companies across 1097 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gajare is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 12% volume in MI $19,878 industry payments

Medicare Practice Summary

Medicare Utilization ↗
830
Medicare services
Top 12% in MI for psychiatry
277
Unique beneficiaries
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~44 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
 280 $80 $137
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
 211 $8 $95
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
 208 $51 $256
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
 119 $62 $126
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
 12 $14 $171
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$19,878
Total received (2018-2024)
Avg $2,840/year across 7 years
Top 3% in MI for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
1,097
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,426 (97.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$452 (2.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,662
2023
$3,702
2022
$3,177
2021
$2,883
2020
$1,456
2019
$2,650
2018
$2,348

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$628
Alkermes, Inc.
$543
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$471
Otsuka America Pharmaceutical, Inc.
$388
ABBVIE INC.
$362
Neurocrine Biosciences, Inc.
$294
Axsome Therapeutics, Inc.
$208
Lundbeck LLC
$198
Janssen Pharmaceuticals, Inc
$168
E.R. Squibb & Sons, L.L.C.
$165
Eisai Inc.
$107
Supernus Pharmaceuticals, Inc.
$60
Indivior Inc.
$52
Takeda Pharmaceuticals U.S.A., Inc.
$18
Top 3 companies account for 44.8% of 2024 payments
All-time payments by company (2018-2024) ›
Otsuka America Pharmaceutical, Inc.
$2,760
Alkermes, Inc.
$2,756
Teva Pharmaceuticals USA, Inc.
$2,038
ITI, Inc.
$1,627
Lundbeck LLC
$1,438
Sunovion Pharmaceuticals Inc.
$1,428
Neurocrine Biosciences, Inc.
$1,249
Janssen Pharmaceuticals, Inc
$1,060
Vanda Pharmaceuticals Inc.
$934
ABBVIE INC.
$832
Takeda Pharmaceuticals U.S.A., Inc.
$780
Allergan Inc.
$667
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$471
Axsome Therapeutics, Inc.
$464
Indivior Inc.
$389
E.R. Squibb & Sons, L.L.C.
$165
Supernus Pharmaceuticals, Inc.
$156
Eisai Inc.
$121
IDORSIA PHARMACEUTICALS US INC
$120
Avanir Pharmaceuticals, Inc.
$120
Corium, LLC
$104
Janssen Biotech, Inc.
$50
AbbVie Inc.
$43
Shire North American Group Inc
$40
Ironshore Pharmaceuticals Inc.
$28
Almatica Pharma LLC
$23
Allergan, Inc.
$12
Top 3 companies account for 38.0% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ARISTADA · AUSTEDO · AZSTARYS · Aristada 441 mg · Austedo XR · Auvelity · BRINTELLIX · BROVANA · CAPLYTA · COBENFY · Dayvigo · Fanapt · GRALISE · HETLIOZ · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LYBALVI · Leqembi · MYDAYIS · NUEDEXTA · PERSERIS · QELBREE · QUVIVIQ · Qelbree · REXULTI · SPRAVATO · TRINTELLIX · Trintellix · UZEDY · VIVITROL · VRAYLAR · VYVANSE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for psychiatry in MI.

Looking for a psychiatry specialist in Kalamazoo?
Compare psychiatrists in the Kalamazoo area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
75
Per 100K population
28.7
County median income
$70,525
Nearest hospital
KALAMAZOO REGIONAL PSYCHIATRIC HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gajare is a clinical cardiology specialist, with above-average Medicare volume (top 12% in MI), with low-engagement industry engagement in the top 3% of MI peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gajare experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gajare performed 280 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gajare receive payments from pharmaceutical companies?
Yes. Dr. Gajare received a total of $19,878 from 27 companies across 1,097 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gajare's costs compare to other psychiatrists in Kalamazoo?
Dr. Gajare's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gajare) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Psychiatrists in Kalamazoo
Browse psychiatrists in Kalamazoo ranked by procedure volume and transparency data.
Highest volume
Top Psychiatrists in MI
Psychiatrists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Psychiatrists in MI
Which MI psychiatrists receive the most from drug and device companies.
By company
Otsuka America Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Otsuka America Pharmaceutical, Inc.
By company
Alkermes, Inc. Payments to Doctors
See all physicians who received payments from Alkermes, Inc.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →